Keywords: emea, approvals, new, biotech, drugs, faster, fda

EMEA approvals of new biotech drugs faster than US FDA, says Tufts study

Article | 28 March 2000

Print This

The European Medicines Evaluation Agency took 417 days on average toapprove 19 new biotechnology drug products launched in Europe and the USA ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in